Dr Paola Villanueva
Dr Paola Villanueva
Details
Role
Research Officer
Research area
Infection, Immunity and Global Health
Group
Infectious Diseases
Contact
Email
show email address
Dr Paola Villanueva is a consultant paediatrician and post-doctoral researcher in the Infectious Diseases Research Group at the Murdoch Children’s Research Institute. She is also a lecturer in medical education and paediatric teaching fellow at the University of Melbourne, and has completed a Simulation Education Fellowship at The Royal Children’s Hospital.
Her PhD research focuses on evaluating the safety of BCG vaccination and how to prevent adverse events. Her work involves vaccine safety surveillance within a large international clinical trial, collaborating with research centres in Australia, Brazil, the UK, the Netherlands and Spain.
Her PhD research focuses on evaluating the safety of BCG vaccination and how to prevent adverse events. Her work involves vaccine safety surveillance within a large international clinical trial, collaborating with research centres in Australia, Brazil, the UK, the Netherlands and Spain.
Dr Paola Villanueva is a consultant paediatrician and post-doctoral researcher in the Infectious Diseases Research Group at the Murdoch Children’s Research Institute. She is also a lecturer in medical education and paediatric teaching fellow at the...
Dr Paola Villanueva is a consultant paediatrician and post-doctoral researcher in the Infectious Diseases Research Group at the Murdoch Children’s Research Institute. She is also a lecturer in medical education and paediatric teaching fellow at the University of Melbourne, and has completed a Simulation Education Fellowship at The Royal Children’s Hospital.
Her PhD research focuses on evaluating the safety of BCG vaccination and how to prevent adverse events. Her work involves vaccine safety surveillance within a large international clinical trial, collaborating with research centres in Australia, Brazil, the UK, the Netherlands and Spain.
Her PhD research focuses on evaluating the safety of BCG vaccination and how to prevent adverse events. Her work involves vaccine safety surveillance within a large international clinical trial, collaborating with research centres in Australia, Brazil, the UK, the Netherlands and Spain.
Top Publications
- Villanueva, P, McDonald, E, Croda, J, Croda, MG, Dalcolmo, M, Dos Santos, G, Jardim, B, Lacerda, M, Lynn, DJ, Marshall, H, et al. Factors influencing adverse events following COVID-19 vaccination.. Hum Vaccin Immunother 20(1) : 2323853 2024 view publication
- Villanueva, P, Crawford, NW, Garcia Croda, M, Collopy, S, Araújo Jardim, B, de Almeida Pinto Jardim, T, Marshall, H, Prat-Aymerich, C, Sawka, A, Sharma, K, et al. Safety of BCG vaccination and revaccination in healthcare workers.. Hum Vaccin Immunother 19(2) : 2239088 2023 view publication
- Villanueva, P, Crawford, NW, Croda, MG, Collopy, S, Jardim, BA, de Almeida Pinto Jardim, T, Manning, L, Lucas, M, Marshall, H, Prat-Aymerich, C, et al. Erratum: Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination.. Heliyon 9(6) : e15821 2023 view publication
- Pittet, LF, Messina, NL, Orsini, F, Moore, CL, Abruzzo, V, Barry, S, Bonnici, R, Bonten, M, Campbell, J, Croda, J, et al. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.. N Engl J Med 388(17) : 1582 -1596 2023 view publication
- Villanueva, P, Crawford, NW, Croda, MG, Collopy, S, Jardim, BA, de Almeida Pinto Jardim, T, Manning, L, Lucas, M, Marshall, H, Prat-Aymerich, C, et al. Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination.. Heliyon 9(4) : e15241 2023 view publication
Page 1 of 4
Share //
